Global assistance, risk and claims management provider CEGA and Millstream Underwriting have announced a new partnership, which will enable the provision of CEGA’s new automated medical screening tool, Antidote, to Millstream’s high-net-worth and other travel insurance customers.
Millstream Underwriting (part of the Nexus Group) specialises in tailoring commercial and retail accident and health insurance solutions, while Antidote is CEGA’s new creation – providing accurate, intelligent risk profiling, while simplifying the medical assessment journey of travel insurance customers by allowing them to ‘self-declare pre-existing medical conditions through logical question sets’.
Tim Brangwyn, Managing Director of Millstream Underwriting, commented: “We chose Antidote for its ability to provide a simple, fast and customer-centric medical screening process, enabled by straightforward questions and easy, well-supported technology. Its versatility also allows us to meet the needs of our clients who need a more tailored screening solution.”
CEGA’s Head of Proposition Development Angela Smith explained that CEGA expected Antidote to ‘pave the way’ for enhanced policy renewals and sales, and that the product would provide Millstream with ‘measurable algorithmic outputs’, as well as ‘consistency in underwriting outcomes’. “Crucially, it also offers ownership of customer data,” she added.
Brangwyn noted: “CEGA’s professionalism, flexibility and alignment with Millstream’s goals were key factors in establishing this important relationship.”